Integrin Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.40 Cr
as on 17-06-2024
- Paid Up Capital ₹ 5.00 Cr
as on 17-06-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.01 Cr
as on 17-06-2024
- Satisfied Charges ₹ 6.95 Cr
as on 17-06-2024
- Revenue 20.72%
(FY 2023)
- Profit 38.55%
(FY 2023)
- Ebitda -3.63%
(FY 2023)
- Net Worth 40.99%
(FY 2023)
- Total Assets 27.14%
(FY 2023)
About Integrin Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.40 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹27.01 Cr. The company has closed loans amounting to ₹6.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dhana Marikanti and Srinivas Marikanti serve as directors at the Company.
- CIN/LLPIN
U24211TG2007PTC052551
- Company No.
052551
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Integrin Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Marikanti  | Managing Director | 02-Sep-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhana Marikanti | Director | 02-Sep-2013 | Current |
Financial Performance of Integrin Lifesciences.
Integrin Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.72% increase. The company also saw a substantial improvement in profitability, with a 38.55% increase in profit. The company's net worth Soared by an impressive increase of 40.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integrin Lifesciences?
In 2023, Integrin Lifesciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Integrin Healthcare Private LimitedActive 15 years 8 monthsDhana Marikanti and Srinivas Marikanti are mutual person
Racemic Labs Private LimitedActive 14 years 9 monthsDhana Marikanti and Srinivas Marikanti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Oct 2023 | ₹4.06 M | Open |
Others Creation Date: 28 Feb 2023 | ₹2.14 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Nov 2021 | ₹1.36 M | Open |
How Many Employees Work at Integrin Lifesciences?
Integrin Lifesciences has a workforce of 111 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrin Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrin Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
